US lawmakers denounce Trump's suggestion of registry for Muslims

November 19, 2016

Washington, Nov 19: Top Democratic lawmakers and rights bodies have slammed President-elect Donald Trump's reported plan to reinstate a database of immigrants from Muslim-majority countries.

hijab

National Security Entry-Exit Registration System (NSEERS) is a post-9/11 program which required travellers to the US from specified Muslim-majority countries to immediately register with the federal government or face deportation.

"Reinstating failed programs that target Arabs and Muslims in our country is exactly what ISIS was cheering on election night when America, a beacon of freedom in the world, gives in to fear and begins chipping away at civil rights, our enemies are emboldened and their ranks swell with new recruits," Senator Dick Durbin said.

"Back in 2002, I called for this program to be terminated because there were serious doubts it would help combat terrorism. Terrorism experts have since concluded that this program wasted precious homeland security funds and alienated Arab- and Muslim-Americans. Failed programs like this are the exact wrong approach to combating terrorism, and I will fight to ensure it never returns," Durbin said.

The Congressional Progressive Caucus (CPC) Co-Chairs Raul M Grijalva and Keith Ellison, Congressional Asian Pacific American Caucus Chairwoman Judy Chu, CPC Vice Chair Congressman Mike Honda, and CPC Vice Chair Mark Takano slammed Trump surrogate, Carl Higbie, for suggesting that Japanese- American internment camps could serve as a precedent for the creation of a Muslim registry.

"These remarks are beyond disturbing. This is fear, not courage. This is hate, not policy," Honda said.

"Since Trump was elected president, thousands of Americans have voiced fears over what our country might look like in the coming years. Last night, one of his surrogates showed us why so many people are afraid of a Trump administration.

"The fact that our incoming President has considered internment as a model for how to move forward with the Muslim community is absolutely shocking. We cannot allow it to be normalised or enacted," Ellison said.

Grijalva said it took the US decades to own up to the stain of Japanese internment, providing compensation to more than 100,000 people who suffered through it and formally apologising through the Civil Liberties Act in 1988. To say this heinous treatment should be precedent for any policy is horrific, and Trump should denounce it immediately.

"Any proposal to force American-Muslims to register with the federal government, and to use Japanese imprisonment during World War II as precedent, is abhorrent and has no place in our society. These ideas are based on tactics of fear, division, and hate that we must condemn," Chu said.

"I am horrified that people connected to the incoming Administration are using my family's experience as a precedent for what President-elect Trump could do," said Takano.

Congresswoman Luis V Gutierrez, a Member of the Judiciary Committee and is Co-Chair of the Immigration Task Force of the Congressional Hispanic Caucus, said the roundup of men from mostly Asian, Middle Eastern and African countries was one of the darkest chapters of the George W Bush years.

It was a strategy to scare immigrants and yielded zero concrete terrorism leads that led to conviction. Racial, ethnic, religious and gender profiling is exactly the wrong approach to law enforcement and counter-terrorism, he said.

"The internment of Japanese-Americans during World War II was a historic injustice and nothing like it should ever happen again. The protection of our Constitution is not conditional; it applies to all of us.

"We cannot allow hate speech, racism, and anti-immigrant sentiment to become the new norm in our country, and we must continue to speak out against hate and prejudice. An inclusive and vibrant America is worth fighting for," Senator Mazie Hironohe said.

Meanwhile, the South Asian Bar Association (SABA) has also denounced the suggestions of a registry for non-citizen Muslims in the US.

"While once just a campaign promise, this xenophobic and un-American idea has been thrust back into our national consciousness by Carl Higbie, former spokesperson for a Super PAC supporting the President-Elect," SABA said in a statement.

Higbie's suggestion that internment camps that imprisoned countless Japanese-Americans during World War II is a "precedent" for a possible Muslim registry, presupposes the lawfulness of a program that's only lasting impact is that of shame, regret and embarrassment, it said.

SABA said this proposed registry is rooted in NSEERS that required certain "foreign citizens and nationals" to continuously check-in with US Authorities.

After repeated criticism and documented ineffectiveness, NSEERS was abandoned in 2011, leaving a legacy of deporting individuals who had committed no crimes and had no links to terrorism, it said.

SABA called on Americans of all backgrounds to reject the notion that registration and potential mass incarceration of residents of this country solely based upon nationality, race or religion, without justification, cause or purpose is acceptable.

"Discrimination towards any community cannot be condoned and we hope the President-Elect and the pending administration uniformly reject such proposals.

The perpetuation of hate solely serves to continue the divisiveness that tears at the core of our values of equal protection and freedom for all individuals," it added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 3,2020

Washington, Jan 3: US President Donald Trump ordered the killing of Iran Revolutionary Guards commander Qasem Soleimani, who died in Baghdad "in a decisive defensive action to protect US personnel abroad," the Pentagon said Thursday.

"General Soleimani was actively developing plans to attack American diplomats and service members in Iraq and throughout the region. General Soleimani and his Quds Force were responsible for the deaths of hundreds of American and coalition service members and the wounding of thousands more," the Department of Defense said.

Following Soleimani's death, Trump tweeted an image of the US flag without any further explanation.

"US' act of international terrorism, assassinating General Soleimani—the most effective force fighting Daesh (ISIS), Al Nusrah,Al Qaeda, is extremely dangerous & foolish escalation. US bears responsibility for all consequences of rogue adventurism." said Iran Foreign Minister Javad Zarif.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 4,2020

Jun 4: A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease.

Results published Wednesday by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the coronavirus.

The drug did not seem to cause serious harm, though -- about 40% on it had side effects, mostly mild stomach problems.

 “We were disappointed. We would have liked for this to work,” said the study leader, Dr. David Boulware, an infectious disease specialist at the University of Minnesota.

“But our objective was to answer the question and to conduct a high-quality study,” because the evidence on the drug so far has been inconclusive, he said.

Hydroxychloroquine and a similar drug, chloroquine, have been the subject of much debate since Trump started promoting them in March.

Hydroxychloroquine has long been used for malaria, lupus, and rheumatoid arthritis, but no large studies have shown it or chloroquine to be safe or effective for much sicker patients with coronavirus, and some studies have suggested the drugs may do harm.

Trump took a two-week course of hydroxychloroquine, along with zinc and Vitamin D, after two staffers tested positive for COVID-19, and had no ill effects, according to results of his latest physical released by his doctor Wednesday.

Federal regulators have warned against hydroxychloroquine's use except in hospitals and formal studies because of the risk of side effects, especially heart rhythm problems.

Boulware's study involved 821 people in the United States and Canada living with someone diagnosed with COVID-19 or at high risk of getting it because of their job -- doctors, nurses, ambulance workers who had significant exposure to a sick patient while not wearing full protective gear.

They were randomly assigned to get either the nutrient folate as a placebo or hydroxychloroquine for five days, starting within four days of their exposure. Neither they nor others involved in the research knew who was getting which pills.

After 14 days in the study, 12 per cent on the drug developed COVID-19 symptoms versus 14 per cent in the placebo group, but the difference is so small it could have occurred by chance, Boulware said.

“There's basically no effect. It does not prevent infection,” he said of the drug. Even if it were to give some slim advantage, “we'd want a much larger effect” to justify its use and risk of side effects for preventing illness, he said.

Results were no different among a subgroup of participants who were taking zinc or vitamin C, which some people believe might help make hydroxychloroquine more effective or fight the coronavirus.

There are some big caveats: The study enrolled people through the Internet and social media, relying on them to report their own symptoms rather than having them tracked in a formal way by doctors.

Participants were not all tested for the coronavirus but were diagnosed as COVID-19 cases based on symptoms in many cases. And not all took their medicines as directed.

The results “are more provocative than definitive,” and the drug may yet have prevention benefits if tried sooner or in a different way, Dr. Myron Cohen of the University of North Carolina at Chapel Hill wrote in a commentary in the journal.

Others were glad to see a study that had a comparison group and good scientific methods after so many weaker reports on hydroxychloroquine.

“This fits with everything else we've seen so far which suggests that it's not beneficial," said Dr. Peter Bach, director of a health policy center at Memorial Sloan Kettering Cancer Center in New York.

This study was in younger relatively healthy people, but the results “would make me very discouraged about trying to use this in older people” who are most vulnerable to serious illness from the coronavirus, Bach said.

“If it does work, it doesn't work very well.” Dr. Dan Culver, a lung specialist at the Cleveland Clinic, said there's still a chance that giving the drug sooner than four days after someone's exposure to the virus may help prevent illness.

But the study “takes 'home run' off the table” as far as hopes for the drug, he said.

The study was mostly funded by David Baszucki, founder of Roblox, a California-based game software company, and other private donors and the Minnesota university.

Boulware also is leading a study testing hydroxychloroquine for treating COVID-19. The study is finished and results are being analyzed now.

On Tuesday, the journal Lancet posted an “expression of concern” about a study it published earlier this month of nearly 15,000 COVID-19 patients on the malaria drugs that tied their use to a higher risk of dying in the hospital or developing a heartbeat problem.

Scientists have raised serious questions about the database used for that study, and its authors have launched an independent audit.

That work had a big impact: the World Health Organization suspended use of hydroxychloroquine in a study it is leading, and French officials stopped the drug's use in hospitals. On Wednesday, the WHO said experts who reviewed safety information decided that its study could resume.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 25,2020

Beijing:  Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.